RELVAR

This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Italy, Japan, Lithuania, Netherlands, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, South Africa

Active ingredients

The drug RELVAR contains a combination of these active pharmaceutical ingredients (APIs):

1 Fluticasone furoate UNII JS86977WNV - FLUTICASONE FUROATE

Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action. Read about Fluticasone furoate

2 Vilanterol UNII 40AHO2C6DG - VILANTEROL TRIFENATATE

Vilanterol is a selective long-acting, beta2-adrenergic agonist (LABA). The pharmacologic effects of beta2-adrenoceptor agonist active substances, including vilanterol, are at least in part attributable to stimulation of intracellular adenylate cyclase, the enzyme that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'-adenosine monophosphate (cyclic AMP). Increased cyclic AMP levels cause relaxation of bronchial smooth muscle and inhibition of release of mediators of immediate hypersensitivity from cells, especially from mast cells. Read about Vilanterol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
RELVAR ELLIPTA Inhalation powder, pre-dispensed	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
R03AK10	Vilanterol and fluticasone furoate	R Respiratory system → R03 Drugs for obstructive airway diseases → R03A Adrenergics, inhalants → R03AK Adrenergics and other drugs for obstructive airway diseases
Discover more medicines within R03AK10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: BR	Câmara de Regulação do Mercado de Medicamentos	Identifier(s): 510614060051902, 510614060052002, 510614060052102, 510614060052202
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 02359975, 02359981, 02360725, 02360754, 16897127, 16897133, 17522375, 17522381, 17824509, 17824515
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 298-MEE-0514, 380-MEE-0714
Country: EE	Ravimiamet	Identifier(s): 1632327, 1632338, 1632349, 1632350, 1632361, 1632372
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 113886002, 113886005
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 125317, 386095, 413225, 495151
Country: FR	Base de données publique des médicaments	Identifier(s): 61740809, 64122611
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 236218, 236221, 375330, 375334, 379941, 379943, 381654, 381656
Country: HK	Department of Health Drug Office	Identifier(s): 62693, 62694
Country: IE	Health Products Regulatory Authority	Identifier(s): 19732, 19733, 19734, 19758
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 7409, 7410
Country: IT	Agenzia del Farmaco	Identifier(s): 043154018, 043154020, 043154032, 043154044, 043154057, 043154069
Country: JP	医薬品医療機器総合機構	Identifier(s): 2290803G1028, 2290803G2024, 2290803G3020, 2290803G4027
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1072104, 1072105, 1072106, 1072107, 1072108, 1072109
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 125334, 125342
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 15585, 15586
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100304330, 100304346
Country: SG	Health Sciences Authority	Identifier(s): 14736P, 14737P
Country: TN	Direction de la Pharmacie et du Médicament	Identifier(s): 2883051, 2883052
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699522559923, 8699522559930, 8699522559947, 8699522559954, 8699522559961, 8699522559978
Country: ZA	Health Products Regulatory Authority	Identifier(s): 48/21.5.1/0250, 48/21.5.1/249